BioRem Inc.'s (CVE:BRM) Stock Is Going Strong: Have Financials A Role To Play?

BioRem's stock rose by 39% recently, with a focus on Return on Equity (ROE) to assess company performance. Despite a high ROE, the company's net income decreased, raising concerns about its growth potential.